LIV Emles at Home ETF

The Samaritan Foundation and Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, has rescheduled its concert gala with a special guest performance by five-time Academy Award-winning composer John Williams and the Boston Pops Esplanade Orchestra, benefiting the Samaritan Foundation, which was to be held on March 24, at Wynn Las Vegas. The black-tie gala is rescheduled to the end of the year to accommodate the possibility of an acclaimed singer to accompany John Williams, a winner of Monday night's Golden Globe awards, fulfill financial deadlines, as well as getting the full benefit of television and radio promotion. "We want our first event to be perfect, and this gives us more time to ensure it. We also anticipate the hotel rates for our guests will be more accommodating in December, rather than costly March Madness month," according to Dianne Thompson, Senior Vice President of Public Affairs & Development for the Foundation. Thompson went on to say, "We especially want to thank everyone's efforts so far to make this 'Thee Event' and remind you the concert is not cancelled; only rescheduled. Both John Williams and the Boston Pops remain committed to performing the concert for the Foundation. Ticket holders for the March 24th date have the choice of keeping their tickets for the new date or receiving a refund." For further information or questions regarding the date change, please contact the Samaritan Foundation offices at 702-735-7001. The new date of the concert gala will be announced later this month. About Samaritan Pharmaceuticals Samaritan Pharmaceuticals is a drug development company driven to discover, develop and commercialize innovative therapeutics for AIDS, cancer and Alzheimer's and heart diseases. Samaritan, in collaboration with Georgetown University, is advancing eight promising compounds out of its rich pipeline of 250 possible drug candidates, all of which have the potential to create revenue-generating opportunities. For additional information, visit www.samaritanpharma.com. About The Samaritan Innovative Science Foundation The Samaritan Innovative Science Foundation (The Samaritan Foundation) is a 501(c)(3) nonprofit organization founded in 2003 by Dr. Janet Greeson, CEO, and Eugene Boyle, CFO of Samaritan Pharmaceuticals (AMEX:LIV). The Foundation's main focus and passion is to meet the unmet medical and social needs of children. For additional information, visit www.samaritanpharma.org.